MetaCap

Celularity (CELU) Stock Chart

NASDAQ: CELUHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.47-0.11 (-6.96%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

CELU technical summary

CELU is trading 25.8% above its 50-day simple moving average of $1.17 and 34.0% above its 200-day average of $1.10. The 50-day average is above the 200-day average, a crossover (often called a "golden cross") that occurred within the last month. The 14-day Relative Strength Index (RSI) is 54.4, within the neutral 30 to 70 band.

Over the past year, the stock ranged from $0.56 (Jun 30, 2026) to $2.55 (Aug 27, 2026); the current price sits 46% of the way from the low to the high. Annualized 30-day volatility is 289.3%. Based on the last session's high, low and close, the classic pivot point is $1.50, with first resistance at $1.54 and first support at $1.44.

These indicators describe past price behavior for Celularity; they are not predictions.

Summary generated from market data by MetaCap's automated system. Methodology

Technical indicators

Beta
—
1Y high
2.55 (Aug 27)
1Y low
0.56 (Jun 30)
Last close
1.47

CELU price performance

1 week

+8.89%

1 month

-4.55%

3 months

+101.37%

6 months

+7.30%

Year to date

+32.43%

1 year

-27.94%

3 years

-50.67%

5 years

-97.96%

CELU price return, excluding dividends.

Moving averages

Simple and exponential moving averages
PeriodSimple (SMA)Exponential (EMA)
5-day1.55Price below1.52Price below
10-day1.46Price above1.47Price below
20-day1.37Price above1.41Price above
50-day1.17Price above1.24Price above
100-day0.9784Price above1.14Price above
200-day1.10Price above1.25Price above

Moving averages are computed from daily closing prices over the past year. What is a moving average?

Pivot points

Classic pivot points
LevelPrice
Resistance 3 (R3)1.64
Resistance 2 (R2)1.60
Resistance 1 (R1)1.54
Pivot point1.50
Support 1 (S1)1.44
Support 2 (S2)1.40
Support 3 (S3)1.34

Classic floor-trader pivots from the last session's high, low and close. How pivot points work

Learn technical analysis